BSCI-17. Targeting SIRPα as a therapeutic strategy for the treatment of breast cancer brain metastasis

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by the lack of druggable targets and an incidence of brain metastasis from the primary site of approximately 35%. There is no standard treatment for managing brain metastasis associated with TNBC; ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirling, Elizabeth R, Bronson, Steven M, Crowe, William N, Wilson, Adam, Kooshki, Mitra, Zhao, Dawen, Triozzi, Pierre L, Lesser, Glenn J, Soto-Pantoja, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351265/
http://dx.doi.org/10.1093/noajnl/vdab071.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351265/
http://dx.doi.org/10.1093/noajnl/vdab071.016

Ejemplares similares